SNDL Inc.SNDLEarnings & Financial Report
Nasdaq · Health Care · Medicinal Chemicals & Botanical Products
SNDL Inc. is a Canada-based consumer goods company focused primarily on the cannabis sector, offering a range of recreational and medical cannabis products, alongside craft beer, wine and spirit offerings. It operates across cultivation, product development, distribution and retail segments, serving both wholesale and retail customers mainly in the North American market.
Revenue
$115.9M
Gross Profit
N/A
Operating Profit
N/A
Net Profit
N/A
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
SNDL Inc. Q1 FY2023 Financial Summary
SNDL Inc. reported revenue of $115.9M for Q1 FY2023, with a net profit of N/A (N/A margin).
Key Financial Metrics
| Total Revenue | $115.9M |
|---|---|
| Net Profit | N/A |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q1 FY2023 |
SNDL Inc. Quarterly Revenue & Net Profit History
SNDL Inc. results over the last 3 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2025 | $77.5M | — | N/A | N/A |
| Q1 FY2024 | $116.1M | — | N/A | N/A |
| Q1 FY2023 | $115.9M | — | N/A | N/A |
Income Statement
| Q1 2023 | Q1 2024 | Q1 2025 | |
|---|---|---|---|
| Revenue | $115.9M | $116.1M | $77.5M |
| YoY Growth | N/A | N/A | N/A |
Balance Sheet
| Q1 2023 | Q1 2024 | Q1 2025 | |
|---|---|---|---|
| Assets | N/A | N/A | N/A |
| Liabilities | N/A | N/A | N/A |
| Equity | N/A | N/A | N/A |
Cash Flow
No data available for this period